Genomic characterisation of acral melanoma cell lines

Pigment Cell and Melanoma Research

Volumn 25, Issue 4, 2012, Pages 488-492

  Furney, Simon J ^a   Turajlic, Samra ^a   Fenwick, Kerry ^a   Lambros, Maryou B ^a   Mackay, Alan ^a   Ricken, Gerda ^a   Mitsopoulos, Costas ^a   Kozarewa, Iwanka ^a   Hakas, Jarle ^a   Zvelebil, Marketa ^a   Lord, Christopher J ^a   Ashworth, Alan ^a   Reis Filho, Jorge S ^a   Herlyn, Meenhard ^b   Murata, Hiroshi ^c   Marais, Richard ^a,d  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b WISTAR INSTITUTE   (United States)

^c SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Acral melanoma; Cell lines; Exome sequencing; Genomics; Mutational signature

Indexed keywords

B RAF KINASE; BRCA1 PROTEIN; BRCA2 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ACRAL MELANOMA; ARTICLE; GENE MUTATION; HUMAN; MELANOMA; MELANOMA CELL; MUTAGENESIS; ONCOGENE N RAS;

CELL LINE, TUMOR; EXOME; GENOME, HUMAN; HUMANS; MELANOMA; MICROSATELLITE REPEATS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS;

EID: 84862702937     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2012.01016.x     Document Type: Article

References (28)

1. Aguissa-Toure, A.H., and Li, G. (2011). Genetic alterations of PTEN in human melanoma. Cell. Mol. Life Sci. 69, 1475-1491.
2. Ashida, A., Takata, M., Murata, H., Kido, K., and Saida, T. (2009). Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Int. J. Cancer 124, 862-868.
3. Beadling, C., Jacobson-Dunlop, E., Hodi, F.S. et al. (2008). KIT gene mutations and copy number in melanoma subtypes. Clin. Cancer Res. 14, 6821-6828.
4. Bradford, P.T., Goldstein, A.M., McMaster, M.L., and Tucker, M.A. (2009). Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005. Arch. Dermatol. 145, 427-434.
5. Chernoff, K.A., Bordone, L., Horst, B. et al. (2009). GAB2 amplifications refine molecular classification of melanoma. Clin. Cancer Res. 15, 4288-4291.
6. Curtin, J.A., Fridlyand, J., Kageshita, T. et al. (2005). Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353, 2135-2147.
7. Curtin, J.A., Busam, K., Pinkel, D., and Bastian, B.C. (2006). Somatic activation of KIT in distinct subtypes of melanoma. J. Clin. Oncol. 24, 4340-4346.
8. Gonzalez-Perez, A., and Lopez-Bigas, N. (2011). Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am. J. Hum. Genet. 88, 440-449.
9. Griewank, K.G., Yu, X., Khalili, J., Sozen, M.M., Stempke-Hale, K., Bernatchez, C., Wardell, S., Bastian, B.C., and Woodman, S.E. (2012). Genetic and molecular characterization of uveal melanoma cell lines. Pigment Cell Melanoma Res. 25, 182-187.
10. Jones, S., Li, M., Parsons, D.W. et al. (2012). Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Hum. Mutat. 33, 100-103.
11. Koboldt, D.C., Chen, K., Wylie, T., Larson, D.E., McLellan, M.D., Mardis, E.R., Weinstock, G.M., Wilson, R.K., and Ding, L. (2009). VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25, 2283-2285.
12. Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Horsman, D., Jones, S.J., and Marra, M.A. (2009). Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639-1645.
13. Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760.
14. McKenna, A., Hanna, M., Banks, E. et al. (2010). The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303.
15. McLaren, W., Pritchard, B., Rios, D., Chen, Y., Flicek, P., and Cunningham, F. (2010). Deriving the consequences of genomic variants with the Ensembl API and SNP effect predictor. Bioinformatics 26, 2069-2070.
16. Murata, H., Ashida, A., Takata, M., Yamaura, M., Bastian, B.C., and Saida, T. (2007). Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas. Cancer Sci. 98, 958-963.
17. Natrajan, R., Weigelt, B., Mackay, A. et al. (2010). An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res. Treat. 121, 575-589.
18. Pfeifer, G.P., and Besaratinia, A. (2012). UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem. Photobiol. Sci. 11, 90-97.
19. Pleasance, E.D., Cheetham, R.K., Stephens, P.J. et al. (2010a). A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196.
20. Pleasance, E.D., Stephens, P.J., O'Meara, S. et al. (2010b). A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184-190.
21. Ritter, M.A., and Williams, J.R. (1981). Fluorescent-light-induced lethality and DNA repair in normal and xeroderma pigmentosum fibroblasts. Biochim. Biophys. Acta 655, 18-25.
22. Satyamoorthy, K., DeJesus, E., Linnenbach, A.J., Kraj, B., Kornreich, D.L., Rendle, S., Elder, D.E., and Herlyn, M. (1997). Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7(Suppl 2), S35-S42.
23. Sauter, E.R., Yeo, U.C., von Stemm, A. et al. (2002). Cyclin D1 is a candidate oncogene in cutaneous melanoma. Cancer Res. 62, 3200-3206.
24. Sparrow, L.E., Soong, R., Dawkins, H.J., Iacopetta, B.J., and Heenan, P.J. (1995). p53 gene mutation and expression in naevi and melanomas. Melanoma Res. 5, 93-100.
25. Stark, M.S., Woods, S.L., Gartside, M.G. et al. (2011). Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nat. Genet. 44, 165-169.
26. Turajlic, S., Furney, S.J., Lambros, M.B. et al. (2012). Whole genome sequencing of matched primary and metastatic acral melanomas. Genome Res. 22, 196-207.
27. Wei, X., Walia, V., Lin, J.C. et al. (2011). Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat. Genet. 43, 442-446.
28. Woodman, S.E., Trent, J.C., Stemke-Hale, K. et al. (2009). Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates. Mol. Cancer Ther. 8, 2079-2085.